Skip to main content
Clinical Trials/NCT02194192
NCT02194192
Completed
Not Applicable

Prophylaxis Ephedrine or Ondansetron Prevents Hypotension After Spinal Anesthesia for Cesarean Section; a Randomized, Double Blinded, Placebo Controlled Trial

Mahidol University1 site in 1 country168 target enrollmentJuly 2014

Overview

Phase
Not Applicable
Intervention
Placebo
Conditions
Anesthesia; Adverse Effect, Spinal and Epidural
Sponsor
Mahidol University
Enrollment
168
Locations
1
Primary Endpoint
Comparing efficacy of ondansetron to ephedrine in the prevention of hypotension.
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Maternal hypotension after spinal anesthesia in parturients undergoing cesarean section is a very common problem leading to several complications to both patients and their babies. It can cause maternal discomfort, lightheadedness, nausea and vomiting. The most important complication is the decreasing blood flow to babies; which may lead to fetal acidosis.

Many interventions has been studied in order to prevent hypotension after spinal anesthesia in cesarean section e.g., fluid loading: colloid vs crystalloid, medications: ephedrine, phenylephrine, and metaraminol, etc. The recent study showed ondansetron (the antiemetic drug) can be effectively used to prevent hypotension after spinal anesthesia in normal patients or parturients. The action of ondansetron is believed to inhibit Bezold-Jarish reflex.

This aim of this study is to compare the efficacy of ephedrine and ondansetron in the prevention of maternal hypotension after spinal anesthesia in cesarean section.

Registry
clinicaltrials.gov
Start Date
July 2014
End Date
March 2015
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years
  • Elective cesarean section
  • Patient accept spinal anesthesia
  • ASA classification I-II
  • Term, Singleton pregnancy
  • Understand all process in this study

Exclusion Criteria

  • DM any type that not the gestational DM
  • Hypertensive disorder
  • Complicated pregnancy such as placenta previa, preeclampsia
  • Allergic to study drugs
  • Long QT syndrome
  • Contraindication to spinal anesthesia

Arms & Interventions

Group P

Normal saline 10 ml

Intervention: Placebo

Group E

Ephedrine 10 mg in Normal Saline 10 ml

Intervention: Ephedrine

Group O

Ondansetron 8 mg in Normal saline 10 ml

Intervention: Ondansetron

Outcomes

Primary Outcomes

Comparing efficacy of ondansetron to ephedrine in the prevention of hypotension.

Time Frame: After spinal block to until baby delivered

Ondansetron or ephedrine will be given immediately after spinal anesthesia, then record blood pressure and heart rate one-minutely until delivery.

Secondary Outcomes

  • Maternal symptom: Nausea and vomiting after spinal anesthesia(After spinal anesthesia until baby delivered)

Study Sites (1)

Loading locations...

Similar Trials